EDGAR Filing Documents for 0001415889-13-000438

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001415889-13-000438

Filing Date

2013-03-18

Accepted

2013-03-18 15:33:37

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	ecte10kdec312012.htm	10-K	1713658
2	EXHIBIT 21.1	ex21-1.htm	EX-21.1	2737
3	EXHIBIT 23.1	ex23-1.htm	EX-23.1	2469
4	EXHIBIT 31.1	ex31-1.htm	EX-31.1	8512
5	EXHIBIT 31.2	ex31-2.htm	EX-31.2	8898
6	EXHIBIT 32.1	ex32-1.htm	EX-32.1	4426
7	EXHIBIT 32.2	ex32-2.htm	EX-32.2	4966
8		echotx.jpg	GRAPHIC	14384
	Complete submission text file	0001415889-13-000438.txt		6674951

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY INSTANCE DOCUMENT	ecte-20121231.xml	EX-101.INS	755969
10	XBRL TAXONOMY SCHEMA DOCUMENT	ecte-20121231.xsd	EX-101.SCH	83895
11	XBRL TAXONOMY CALCULATION DOCUMENT	ecte-20121231_cal.xml	EX-101.CAL	56311
12	XBRL TAXONOMY DEFINITION DOCUMENT	ecte-20121231_def.xml	EX-101.DEF	133187
13	XBRL TAXONOMY LABEL DOCUMENT	ecte-20121231_lab.xml	EX-101.LAB	503144
14	XBRL TAXONOMY PRESENTATION DOCUMENT	ecte-20121231_pre.xml	EX-101.PRE	304758

Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103

Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)